US Stock MarketDetailed Quotes

Beamr Imaging (BMR)

Watchlist
  • 1.830
  • +0.030+1.67%
Close Apr 17 15:59 ET
  • 1.840
  • +0.010+0.54%
Post 20:01 ET
28.42MMarket Cap-4.69P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Beamr Imaging (BMR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(FY)Dec 31, 2024
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
Total revenue
0.98%3.09M
5.33%3.06M
1.61%2.91M
-13.24%2.86M
3.90%3.3M
3.18M
Operating revenue
0.98%3.09M
5.33%3.06M
1.61%2.91M
-13.24%2.86M
3.90%3.3M
--3.18M
Cost of revenue
32.50%318K
150.00%240K
-2.04%96K
8.89%98K
-4.26%90K
94K
Gross profit
-1.70%2.78M
0.39%2.82M
1.74%2.81M
-13.86%2.77M
4.15%3.21M
3.08M
Operating expense
52.84%9.23M
63.61%6.04M
-2.77%3.69M
0.85%3.8M
-20.74%3.76M
4.75M
Selling and administrative expenses
47.26%4.6M
69.28%3.13M
7.89%1.85M
3.63%1.71M
-7.61%1.65M
--1.79M
-Selling and marketing expense
133.19%527K
218.31%226K
-14.46%71K
7.79%83K
-41.67%77K
--132K
-General and administrative expense
40.57%4.08M
63.32%2.9M
9.03%1.78M
3.43%1.63M
-4.89%1.57M
--1.66M
Research and development costs
59.11%4.6M
58.61%2.89M
-11.59%1.82M
1.53%2.06M
-25.49%2.03M
--2.73M
Depreciation amortization depletion
19.05%25K
0.00%21K
-4.55%21K
-72.84%22K
-68.24%81K
--255K
-Depreciation and amortization
19.05%25K
0.00%21K
-4.55%21K
-72.84%22K
-68.24%81K
--255K
Other operating expenses
----
----
----
----
----
---20K
Operating profit
-100.75%-6.45M
-266.17%-3.22M
14.84%-878K
-86.10%-1.03M
66.77%-554K
-1.67M
Net non-operating interest income expense
4.56%504K
501.67%482K
15.49%-120K
4.70%-142K
73.20%-149K
-556K
Non-operating interest income
-8.19%549K
516.49%598K
--97K
--0
--0
----
Non-operating interest expense
-61.21%45K
-43.41%116K
44.37%205K
140.68%142K
-50.83%59K
--120K
Total other finance cost
----
----
--12K
----
-79.36%90K
--436K
Other net income (expense)
90.42%-55K
-267.84%-574K
1,586.96%342K
88.32%-23K
-39.72%-197K
-141K
Gain on sale of security
90.42%-55K
-267.84%-574K
1,586.96%342K
88.32%-23K
-39.72%-197K
---141K
Income before tax
-81.58%-6.01M
-404.12%-3.31M
45.15%-656K
-32.89%-1.2M
61.93%-900K
-2.36M
Income tax
-67.39%15K
17.95%46K
-25.00%39K
0.00%52K
-45.26%52K
95K
Net income
-79.54%-6.02M
-382.45%-3.35M
44.31%-695K
-31.09%-1.25M
61.29%-952K
-2.46M
Net income continuous Operations
-79.54%-6.02M
-382.45%-3.35M
44.31%-695K
-31.09%-1.25M
61.29%-952K
---2.46M
Minority interest income
Net income attributable to the parent company
-79.54%-6.02M
-382.45%-3.35M
44.31%-695K
-31.09%-1.25M
61.29%-952K
-2.46M
Preferred stock dividends
Other preferred stock dividends
0
0
7K
0
Net income attributable to common stockholders
-79.54%-6.02M
-377.64%-3.35M
43.75%-702K
-31.09%-1.25M
61.29%-952K
-2.46M
Basic earnings per share
-77.27%-0.39
-144.44%-0.22
81.25%-0.09
-30.02%-0.48
61.29%-0.3692
-0.9536
Diluted earnings per share
-77.27%-0.39
-144.44%-0.22
81.25%-0.09
-30.02%-0.48
61.29%-0.3692
-0.9536
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
--
--
--
(FY)Dec 31, 2025(FY)Dec 31, 2024(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020
Total revenue 0.98%3.09M5.33%3.06M1.61%2.91M-13.24%2.86M3.90%3.3M3.18M
Operating revenue 0.98%3.09M5.33%3.06M1.61%2.91M-13.24%2.86M3.90%3.3M--3.18M
Cost of revenue 32.50%318K150.00%240K-2.04%96K8.89%98K-4.26%90K94K
Gross profit -1.70%2.78M0.39%2.82M1.74%2.81M-13.86%2.77M4.15%3.21M3.08M
Operating expense 52.84%9.23M63.61%6.04M-2.77%3.69M0.85%3.8M-20.74%3.76M4.75M
Selling and administrative expenses 47.26%4.6M69.28%3.13M7.89%1.85M3.63%1.71M-7.61%1.65M--1.79M
-Selling and marketing expense 133.19%527K218.31%226K-14.46%71K7.79%83K-41.67%77K--132K
-General and administrative expense 40.57%4.08M63.32%2.9M9.03%1.78M3.43%1.63M-4.89%1.57M--1.66M
Research and development costs 59.11%4.6M58.61%2.89M-11.59%1.82M1.53%2.06M-25.49%2.03M--2.73M
Depreciation amortization depletion 19.05%25K0.00%21K-4.55%21K-72.84%22K-68.24%81K--255K
-Depreciation and amortization 19.05%25K0.00%21K-4.55%21K-72.84%22K-68.24%81K--255K
Other operating expenses -----------------------20K
Operating profit -100.75%-6.45M-266.17%-3.22M14.84%-878K-86.10%-1.03M66.77%-554K-1.67M
Net non-operating interest income expense 4.56%504K501.67%482K15.49%-120K4.70%-142K73.20%-149K-556K
Non-operating interest income -8.19%549K516.49%598K--97K--0--0----
Non-operating interest expense -61.21%45K-43.41%116K44.37%205K140.68%142K-50.83%59K--120K
Total other finance cost ----------12K-----79.36%90K--436K
Other net income (expense) 90.42%-55K-267.84%-574K1,586.96%342K88.32%-23K-39.72%-197K-141K
Gain on sale of security 90.42%-55K-267.84%-574K1,586.96%342K88.32%-23K-39.72%-197K---141K
Income before tax -81.58%-6.01M-404.12%-3.31M45.15%-656K-32.89%-1.2M61.93%-900K-2.36M
Income tax -67.39%15K17.95%46K-25.00%39K0.00%52K-45.26%52K95K
Net income -79.54%-6.02M-382.45%-3.35M44.31%-695K-31.09%-1.25M61.29%-952K-2.46M
Net income continuous Operations -79.54%-6.02M-382.45%-3.35M44.31%-695K-31.09%-1.25M61.29%-952K---2.46M
Minority interest income
Net income attributable to the parent company -79.54%-6.02M-382.45%-3.35M44.31%-695K-31.09%-1.25M61.29%-952K-2.46M
Preferred stock dividends
Other preferred stock dividends 007K0
Net income attributable to common stockholders -79.54%-6.02M-377.64%-3.35M43.75%-702K-31.09%-1.25M61.29%-952K-2.46M
Basic earnings per share -77.27%-0.39-144.44%-0.2281.25%-0.09-30.02%-0.4861.29%-0.3692-0.9536
Diluted earnings per share -77.27%-0.39-144.44%-0.2281.25%-0.09-30.02%-0.4861.29%-0.3692-0.9536
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSD
Audit Opinions Unqualified OpinionUnqualified OpinionUnqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -